The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma

Item

http://www.wikidata.org/entity/Q36557416

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@ast

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@en

type

Item

label

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@ast

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@en

prefLabel

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@ast

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@en

P1476

The effect of specialized canc ...... efficacy in Hodgkin's lymphoma

@en

P2093

Andreas Engert

http://www.w3.org/2001/XMLSchema#string

Beate Klimm

http://www.w3.org/2001/XMLSchema#string

Corinne Brillant

http://www.w3.org/2001/XMLSchema#string

Horst Müller

http://www.w3.org/2001/XMLSchema#string

Peter Borchmann

http://www.w3.org/2001/XMLSchema#string

P2860

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Current treatment strategies of the German Hodgkin Study Group (GHSG).

P304

893-899

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2012.0893

http://www.w3.org/2001/XMLSchema#string

P433

51-52

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Nicole Skoetz

P577

2012-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23372613

http://www.w3.org/2001/XMLSchema#string

P932

3553394

http://www.w3.org/2001/XMLSchema#string